Alain Garnier - Publications

Affiliations: 
Universite Laval (Canada) 
Area:
Chemical Engineering, Microbiology Biology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mangion M, Gélinas JF, Bakhshi Zadeh Gashti A, Azizi H, Kiesslich S, Nassoury N, Chahal PS, Kobinger G, Gilbert R, Garnier A, Gaillet B, Kamen A. Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures. Vaccine. PMID 33139138 DOI: 10.1016/j.vaccine.2020.10.058  0.36
2015 Garnier A, Gaillet B. Analytical solution of Luedeking-Piret equation for a batch fermentation obeying Monod growth kinetics. Biotechnology and Bioengineering. 112: 2468-74. PMID 26038085 DOI: 10.1002/bit.25669  0.36
2014 Juneau PM, Garnier A, Duchesne C. The undecimated wavelet transform-multivariate image analysis (UWT-MIA) for simultaneous extraction of spectral and spatial information Chemometrics and Intelligent Laboratory Systems. DOI: 10.1016/j.chemolab.2014.09.007  0.36
2013 Juneau PM, Garnier A, Duchesne C. Selection and tuning of a fast and simple phase-contrast microscopy image segmentation algorithm for measuring myoblast growth kinetics in an automated manner. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 19: 855-66. PMID 23718977 DOI: 10.1017/S143192761300161X  0.36
2013 Segura MM, Mangion M, Gaillet B, Garnier A. New developments in lentiviral vector design, production and purification. Expert Opinion On Biological Therapy. 13: 987-1011. PMID 23590247 DOI: 10.1517/14712598.2013.779249  0.36
2012 Michaud FT, Havugimana PC, Duchesne C, Sanschagrin F, Bernier A, Lévesque RC, Garnier A. Cell culture tracking by multivariate analysis of raw LCMS data. Applied Biochemistry and Biotechnology. 167: 474-88. PMID 22562494 DOI: 10.1007/s12010-012-9661-4  0.36
2012 Robert A, Cortin V, Garnier A, Pineault N. Megakaryocyte and platelet production from human cord blood stem cells. Methods in Molecular Biology (Clifton, N.J.). 788: 219-47. PMID 22130711 DOI: 10.1007/978-1-61779-307-3_16  0.36
2011 Segura MM, Kamen AA, Garnier A. Overview of current scalable methods for purification of viral vectors. Methods in Molecular Biology (Clifton, N.J.). 737: 89-116. PMID 21590394 DOI: 10.1007/978-1-61779-095-9_4  0.36
2011 Pineault N, Cortin V, Boyer L, Garnier A, Robert A, Thérien C, Roy DC. Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. Cytotherapy. 13: 467-80. PMID 21090916 DOI: 10.3109/14653249.2010.530651  0.36
2010 Segura MM, Garnier A, Durocher Y, Ansorge S, Kamen A. New protocol for lentiviral vector mass production. Methods in Molecular Biology (Clifton, N.J.). 614: 39-52. PMID 20225034 DOI: 10.1007/978-1-60761-533-0_2  0.36
2009 Michaud FT, Garnier A, Lemieux L, Duchesne C. Multivariate analysis of single quadrupole LC-MS spectra for routine characterization and quantification of intact proteins. Proteomics. 9: 512-20. PMID 19137552 DOI: 10.1002/pmic.200800300  0.36
2009 Cortin V, Pineault N, Garnier A. Ex vivo megakaryocyte expansion and platelet production from human cord blood stem cells. Methods in Molecular Biology (Clifton, N.J.). 482: 109-26. PMID 19089352 DOI: 10.1007/978-1-59745-060-7_7  0.36
2008 Segura MM, Kamen A, Garnier A. Purification of retrovirus particles using heparin affinity chromatography. Methods in Molecular Biology (Clifton, N.J.). 434: 1-11. PMID 18470635 DOI: 10.1007/978-1-60327-248-3_1  0.36
2008 Segura MM, Garnier A, Di Falco MR, Whissell G, Meneses-Acosta A, Arcand N, Kamen A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. Journal of Virology. 82: 1107-17. PMID 18032515 DOI: 10.1128/JVI.01909-07  0.36
2007 Gilbert PA, Kamen A, Bernier A, Garnier A. A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus. Biotechnology and Bioengineering. 98: 239-51. PMID 17597100 DOI: 10.1002/bit.21340  0.36
2007 Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnology and Bioengineering. 98: 789-99. PMID 17461423 DOI: 10.1002/bit.21467  0.36
2007 Gaillet B, Gilbert R, Amziani R, Guilbault C, Gadoury C, Caron AW, Mullick A, Garnier A, Massie B. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnology Progress. 23: 200-9. PMID 17269689 DOI: 10.1021/bp060187j  0.36
2007 Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, Auger M, Garnier A, Levesque RC. Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. Fems Microbiology Letters. 266: 201-9. PMID 17233731 DOI: 10.1111/j.1574-6968.2006.00523.x  0.36
2007 Segura MM, Kamen A, Lavoie MC, Garnier A. Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 846: 124-31. PMID 16971193 DOI: 10.1016/j.jchromb.2006.08.032  0.36
2006 Ghani K, Garnier A, Coelho H, Transfiguracion J, Trudel P, Kamen A. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnology and Bioengineering. 95: 653-60. PMID 16947907 DOI: 10.1002/bit.20947  0.36
2006 Segura MM, Kamen A, Garnier A. Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnology Advances. 24: 321-37. PMID 16448798 DOI: 10.1016/j.biotechadv.2005.12.001  0.36
2006 Segura MM, Garnier A, Kamen A. Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. Journal of Virological Methods. 133: 82-91. PMID 16325928 DOI: 10.1016/j.jviromet.2005.10.030  0.36
2005 Segura MM, Kamen A, Trudel P, Garnier A. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnology and Bioengineering. 90: 391-404. PMID 15812800 DOI: 10.1002/bit.20301  0.36
2004 Cortin V, Thibault J, Jacob D, Garnier A. High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnology Progress. 20: 858-63. PMID 15176892 DOI: 10.1021/bp034237l  0.36
2003 Jardon M, Garnier A. PH, pCO2, and temperature effect on R-adenovirus production. Biotechnology Progress. 19: 202-8. PMID 12573026 DOI: 10.1021/bp025585a  0.36
2000 Gilbert PA, Garnier A, Jacob D, Kamen A. On-line measurement of green fluorescent protein (GFP) fluorescence for the monitoring of recombinant adenovirus production Biotechnology Letters. 22: 561-567. DOI: 10.1023/A:1005672410905  0.36
2000 Pouliot K, Thibault J, Garnier A, Leiva GA. KLa evaluation during the course of fermentation using data reconciliation techniques Bioprocess Engineering. 23: 565-573. DOI: 10.1007/s004490000198  0.36
1998 Côté J, Garnier A, Massie B, Kamen A. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells Biotechnology and Bioengineering. 59: 567-575. PMID 10099373 DOI: 10.1002/(SICI)1097-0290(19980905)59:5<567::AID-BIT6>3.0.CO;2-8  0.36
1997 Côté J, Bourget L, Garnier A, Kamen A. Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring Biotechnology Progress. 13: 709-714. PMID 9413130 DOI: 10.1021/bp970110i  0.36
1990 Garnier A, Chavarie C, Andre G, Klvana D. The inverse fluidization airlift bioreactor, part i: Hydrodynamic studies Chemical Engineering Communications. 98: 31-45. DOI: 10.1080/00986449008911559  0.36
Show low-probability matches.